A Nomogram to Predict Prognostic Value of Red Cell Distribution Width in Patients with Esophageal Cancer

Table 2

Univariate and multivariate analyses of CSS in ESCC patients.

	CSS %	value	Univariate analysis; HR (95% CI)	value	Multivariate analysis; HR (95% CI)	value
Age (years)		0.579		0.583	—	—
≤60	38.0		1.000
>60	36.1		1.088 (0.806–1.468)
Gender		0.182		0.189	—	—
Female	51.4		1.000
Male	35.0		1.387 (0.851–2.260)
Tumor length (cm)		<0.001		0.001		0.385
≤3.0	53.8		1.000		1.000
>3.0	30.7		1.918 (1.328–2.769)		1.198 (0.797–1.799)
Tumor location		0.331		0.337	—	—
Upper/middle	41.3		1.000
Lower	32.8		1.157 (0.859–1.558)
Vessel invasion		0.003		0.003		0.547
Negative	40.5		1.000		1.000
Positive	20.0		1.738 (1.203–2.511)		1.125 (0.767–1.652)
Differentiation		0.029		0.033		0.061
Well/moderate	39.2		1.000		1.000
Poor	29.1		1.476 (1.033–2.109)		1.418 (0.984–2.043)
T stage		<0.001		<0.001		0.011
T1-2	57.7		1.000		1.000
T3-4	26.1		2.371 (1.668–3.369)		1.683 (1.129–2.508)
N stage		<0.001		<0.001		<0.001
N0	54.7		1.000		1.000
N1–3	16.5		2.846 (2.089–3.877)		2.279 (1.640–3.165)
Adjuvant therapy		0.121		0.126	—	—
No	40.3		1.000
Yes	30.2		1.277 (0.934–1.746)
RDW (%)		<0.001		<0.001		0.036
<14.5	43.9		1.000		1.000
≥14.5	23.3		1.719 (1.268–2.331)		1.396 (1.022–1.908)